Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Schey

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Hematology (Amsterdam, Netherlands)|June 16, 2001
Stem Cell Transplantation for Chronic Lymphocytic Leukaemia: Is this the Way Forward in the New Millennium?; Malignancy; Current Clinical PracticeS. A. Schey
Hematology (Amsterdam, Netherlands)|July 10, 2003
Thalidomide in the management of multiple myelomaS A Schey
Bone Marrow Transplantation|January 7, 1998
Reversible cortical blindness and convulsions with cyclosporin A toxicity in a patient undergoing allogeneic peripheral stem cell transplantationB Madan, S A Schey
British Journal of Haematology|October 29, 2000
Cytomegalovirus colitis after autologous transplantation for multiple myelomaD J Ramsey, S A Schey
Clinical and Laboratory Haematology|August 8, 2001
The effects of prior induction therapy with melphalan on subsequent peripheral blood progenitor cell transplantation for myelomaM A Kazmi, G Ahsan, S A Schey
European Journal of Haematology|December 17, 1998
The use of intravenous intermediate dose melphalan and dexamethasone as induction treatment in the management of de novo multiple myelomaS A Schey, M Kazmi, R Ireland, et al.
Bone Marrow Transplantation|April 20, 2004
Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidationM Streetly, M Kazmi, D Radia, et al.
British Journal of Haematology|February 1, 1991
A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonistsP J Ross, M J Shearer, A T Diplock, et al.
Leukemia Research|April 10, 2007
The incidence and survival of Waldenström's Macroglobulinaemia in South East EnglandK J Phekoo, R H Jack, E Davies, et al.
Journal of Clinical Pathology|August 1, 1985
Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studiesD S Robinson, J V Melo, C Andrews, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Hematology (Amsterdam, Netherlands)|June 16, 2001
Stem Cell Transplantation for Chronic Lymphocytic Leukaemia: Is this the Way Forward in the New Millennium?; Malignancy; Current Clinical PracticeS. A. Schey
Hematology (Amsterdam, Netherlands)|July 10, 2003
Thalidomide in the management of multiple myelomaS A Schey
Bone Marrow Transplantation|January 7, 1998
Reversible cortical blindness and convulsions with cyclosporin A toxicity in a patient undergoing allogeneic peripheral stem cell transplantationB Madan, S A Schey
British Journal of Haematology|October 29, 2000
Cytomegalovirus colitis after autologous transplantation for multiple myelomaD J Ramsey, S A Schey
Clinical and Laboratory Haematology|August 8, 2001
The effects of prior induction therapy with melphalan on subsequent peripheral blood progenitor cell transplantation for myelomaM A Kazmi, G Ahsan, S A Schey
European Journal of Haematology|December 17, 1998
The use of intravenous intermediate dose melphalan and dexamethasone as induction treatment in the management of de novo multiple myelomaS A Schey, M Kazmi, R Ireland, et al.
Bone Marrow Transplantation|April 20, 2004
Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidationM Streetly, M Kazmi, D Radia, et al.
British Journal of Haematology|February 1, 1991
A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonistsP J Ross, M J Shearer, A T Diplock, et al.
Leukemia Research|April 10, 2007
The incidence and survival of Waldenström's Macroglobulinaemia in South East EnglandK J Phekoo, R H Jack, E Davies, et al.
Journal of Clinical Pathology|August 1, 1985
Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studiesD S Robinson, J V Melo, C Andrews, et al.
Pageof 2